Quantum BioPharma Ltd. Adjustments For Unrealised Foreign Exchange Losses Gains
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Unrealised Foreign Exchange Losses Gains of $934.10 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-31.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2023-03-31
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2022-12-31 | $934.10K 20-F · filed 2023-03-31 |
| 2021-12-31 | $0.00 20-F · filed 2023-03-31 |
| 2020-12-31 | -$327.16K 20-F · filed 2023-03-31 |
| 2019-12-31 | $0.00 20-F · filed 2022-03-31 |